Free Trial

BioXcel Therapeutics (BTAI) SEC Filings & 10K Form

BioXcel Therapeutics logo
$1.87 +0.02 (+1.08%)
Closing price 04/25/2025 04:00 PM Eastern
Extended Trading
$1.83 -0.04 (-2.35%)
As of 04/25/2025 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent BioXcel Therapeutics SEC Filings

DateFilerForm TypeView
04/04/2025
3:16 PM
BioXcel Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/03/2025
3:32 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2025
3:30 PM
BioXcel Therapeutics (Filer)
Form 424B5
04/01/2025
5:08 PM
BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
5:02 PM
BioXcel Therapeutics (Issuer)
MACK DAVID J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
5:02 PM
BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
5:04 PM
BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
5:06 PM
BioXcel Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
5:07 PM
BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
5:08 PM
BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
4:00 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2025
6:00 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2025
5:35 PM
BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
5:36 PM
BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
5:37 PM
BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
5:38 PM
BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
8:21 PM
BioXcel Therapeutics (Issuer)
MACK DAVID J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:51 AM
BioXcel Therapeutics (Filer)
Form 424B5
03/03/2025
7:42 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
4:27 PM
ARMISTICE CAPITAL, LLC (Filed by)
BioXcel Therapeutics (Subject)
Form SCHEDULE 13G
02/06/2025
7:44 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2025
4:28 PM
BioXcel Therapeutics (Issuer)
MACK DAVID J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
3:15 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/20/2025
11:15 PM
BioXcel Therapeutics (Filer)
Form EFFECT
01/16/2025
7:00 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2025
7:03 AM
BioXcel Therapeutics (Issuer)
Patni Rajiv (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/16/2025
7:04 AM
BioXcel Therapeutics (Issuer)
Patni Rajiv (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
7:00 PM
BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
7:01 PM
BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
7:03 PM
BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
3:45 PM
BioXcel Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/08/2025
6:45 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/30/2024
3:15 PM
BioXcel Therapeutics (Filer)
Form DEF 14A
12/18/2024
7:19 PM
BioXcel Therapeutics (Subject)
Oaktree Capital Group Holdings GP, LLC (Filed by)
Form SCHEDULE 13G
12/18/2024
4:16 PM
BioXcel Therapeutics (Filer)
Form PRE 14A
12/18/2024
4:20 PM
BioXcel Therapeutics (Subject)
Qatar Investment Authority (Filed by)
Form SCHEDULE 13G
12/17/2024
5:10 PM
BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
5:03 PM
BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
5:04 PM
BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
5:06 PM
BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
5:08 PM
BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Elon Set to Shock the World by May 1st ? (Ad)

Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believes will be Elon’s greatest invention ever… Yes, even bigger than Tesla or SpaceX.

Click here now because after May 1st, it could be too late.
12/16/2024
3:21 PM
BioXcel Therapeutics (Subject)
O'Neill Vincent (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
2:33 PM
BioXcel Therapeutics (Subject)
Steinhart Richard I (Reporting)
Form 144/A
12/16/2024
2:23 PM
BioXcel Therapeutics (Subject)
Yocca Frank (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
2:00 PM
BioXcel Therapeutics (Subject)
Steinhart Richard I (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
1:10 PM
BioXcel Therapeutics (Subject)
Mehta Vimal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
3:05 PM
BioXcel Therapeutics (Issuer)
MACK DAVID J. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/25/2024
3:06 PM
BioXcel Therapeutics (Issuer)
MACK DAVID J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
5:00 AM
BioXcel Therapeutics (Filer)
Form 424B5
11/21/2024
3:43 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2024
3:46 PM
BioXcel Therapeutics (Filer)
Form 424B5
11/14/2024
8:10 AM
BioXcel Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/14/2024
6:00 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
3:08 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
8:53 PM
BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
8:54 PM
BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
8:54 PM
BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
8:55 PM
BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
8:55 PM
BioXcel Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
3:33 PM
BioXcel Therapeutics (Subject)
Wiley Matthew T. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
3:40 PM
BioXcel Therapeutics (Subject)
Rodriguez Javier (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
3:17 PM
BioXcel Therapeutics (Subject)
Yocca Frank (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/19/2024
6:00 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
6:17 PM
BioXcel Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
Form 4/A
09/17/2024
6:18 PM
BioXcel Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
6:19 PM
BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
6:20 PM
BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
6:21 PM
BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
6:21 PM
BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
6:23 PM
BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
4:42 PM
BioXcel Therapeutics (Subject)
Yocca Frank (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
4:26 PM
BioXcel Therapeutics (Subject)
Wiley Matthew T. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
4:16 PM
BioXcel Therapeutics (Subject)
Rodriguez Javier (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
2:48 PM
BioXcel Therapeutics (Subject)
O'Neill Vincent (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
1:58 PM
BioXcel Therapeutics (Subject)
Steinhart Richard I (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
12:23 PM
BioXcel Therapeutics (Subject)
Mehta Vimal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/10/2024
9:47 AM
BioXcel Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
09/09/2024
3:15 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
6:16 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
6:05 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2024
3:41 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2024
6:00 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
6:05 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2024
8:22 PM
BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
Form 4/A
06/18/2024
8:24 PM
BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:25 PM
BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:25 PM
BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:26 PM
BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:26 PM
BioXcel Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:27 PM
BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
2:13 PM
BioXcel Therapeutics (Subject)
Rodriguez Javier (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Trump’s Secret Social Security Plan? (Ad)

In less than a decade, Social Security could be out of money. But a surprising plan from Trump’s inner circle may not just save the system — it could unlock a major opportunity for savvy investors. Financial insider Jim Rickards calls it “Social Prosperity,” and says those who act now could see the biggest gains.

Find out how Trump’s plan could rescue your retirement
06/17/2024
1:34 PM
BioXcel Therapeutics (Subject)
Wiley Matthew T. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
1:09 PM
BioXcel Therapeutics (Subject)
O'Neill Vincent (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
12:46 PM
BioXcel Therapeutics (Subject)
Yocca Frank (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
12:04 PM
BioXcel Therapeutics (Subject)
Mehta Vimal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
12:21 PM
BioXcel Therapeutics (Subject)
Steinhart Richard I (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/11/2024
6:00 PM
BioXcel Therapeutics (Issuer)
Bray June (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:00 PM
BioXcel Therapeutics (Issuer)
MILLER MICHAEL PATRICK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:01 PM
BioXcel Therapeutics (Issuer)
MUELLER PETER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:01 PM
BioXcel Therapeutics (Issuer)
Laumas Sandeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BTAI) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners